CSIMarket Company Name, Ticker, Suppliers, else..


Insulet Corporation  (NASDAQ: PODD)
Other Ticker:  
 

Insulet Corporation

PODD's Fundamental analysis



Looking into Insulet growth rates, revenue grew by 25.7 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1142

Medical Equipment & Supplies industry recorded growth of revenues by 1.71 %

Insulet's net income grew by 49.33 % in III. Quarter 2024 year on year, above company average,

• More on PODD's Growth


Insulet
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Insulet PEG ratio is at 0.22 Company is currently trading with Price to Cash flow multiple of 95.45 in trailing twelve-month period.
Company
49.91
PE TTM   
Industry
1286.47
PE TTM    
Company's Price to Sales ratio is at 10.45.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.79.


• More on PODD's Valuation
 
 Total Debt (Millions $) 1,398
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 661,300
 Net Income/Employee (TTM) $ 140,300
 Receivable Turnover (TTM) 8.06
 Tangible Book Value (Per Share $) 13.07

Insulet
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Insulet PEG ratio is at 0.22 Company is currently trading with Price to Cash flow multiple of 95.45 in trailing twelve-month period.
Company
49.91
PE TTM   
Industry
1286.47
PE TTM    
Company's Price to Sales ratio is at 10.45.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.79.

Insulet Price to Book Ratio is at 18.54 lower than Industry Avg. of 2519.13. and higher than S&P 500 Avg. of 0.01

• More on PODD's Valuation

•  Market Capitalization (Millions $) 20,732
•  Shares Outstanding (Millions) 74
•  Employees 3,000
•  Revenues (TTM) (Millions $) 1,984
•  Net Income (TTM) (Millions $) 421
•  Cash Flow (TTM) (Millions $) 217
•  Capital Exp. (TTM) (Millions $) -110
•  Total Debt (Millions $) 1,398
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 661,300
•  Net Income/Employee(TTM) $ 140,300
•  Receivable Turnover Ratio (TTM) 8.06
•  Tangible Book Value (Per Share $) 13.07

•  Market Capitalization (Millions $) 20,732
•  Shares Outstanding (Millions) 74
•  Employees 3,000
•  Revenues (TTM) (Millions $) 1,984
•  Net Income (TTM) (Millions $) 421
•  Cash Flow (TTM) (Millions $) 217
•  Capital Exp. (TTM) (Millions $) -110


    PODD's Profitability Comparisons
Insulet achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 16.2 % from 11.18 % in II. Quarter.

Insulet net profit margin of 14.25 % is currently ranking no. 23 in Medical Equipment & Supplies industry, ranking no. 82 in Healthcare sector and number 1005 in S&P 500.


Profitability by Segment
Total 14.25 %



  Ratio
•   Capital Ratio (MRQ) 3.68
•  Total Debt to Equity (MRQ) 1.25
•  Tangible Leverage Ratio (MRQ) 1.97
•  Asset Turnover Ratio (TTM) 0.71
•  Inventory Turnover Ratio (TTM) 1.42



Insulet achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2024 to 16.2 % from 11.18 % in II. Quarter.

Insulet net profit margin of 14.25 % is currently ranking no. 23 in Medical Equipment & Supplies industry, ranking no. 82 in Healthcare sector and number 1005 in S&P 500.

• More on PODD's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com